NCT06847256

Brief Summary

The goal of this observational study is to examine the effect of the Cystic Fibrosis (CF) Carrier state on the risk for dehydration and other CF-specific fluid-and-electrolyte disorders in male and female adults. The primary aim of the study is to estimate the risk of electrolyte disorders attributable to the CF carrier state in a genotyped cohort. This will be accomplished with two smaller projects- Aim 1 and Aim 2. Aim 1 will consist of 100 CF Carriers and 100 age- and sex-matched controls. Participants in this aim will be asked to complete a Participant Info and Temperature Survey consisting of questions about race, ethnicity, medical history, and how they experience heat. Aim 2 will consist of a subset of 25 CF Carriers and 25 age- and sex-matched controls from Aim 1. Participants in this aim will be scheduled for a visit to complete a heat challenge. At this visit, they will also complete the Participant Info and Temperature Survey. They will also sit in a sauna at 62 - 63 degrees Celsius for 45 minutes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Nov 2025Dec 2026

First Submitted

Initial submission to the registry

February 14, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 26, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

November 19, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

February 14, 2025

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • Participant Scores for Temperature Sensitivity and Regulation Survey

    Individual and composite scores for 5 components of the Temperature Sensitivity Survey (Heat- and Activity-Induced Autonomic Thermoregulation; Heat-Induced Behavioral Thermoregulation; Heat Perception; and Heat- and Activity-Induced Fatigue). For these 5 components, there are a total of 25 questions. All questions are on a 7-point scale, with the highest representing the most sensitive to heat and the lowest being the least sensitive. We will add up the scores for each question to arrive at a composite score for each component and the component scores will be added to arrive at a total score. Scores will be compared between groups.

    Baseline

  • Change in Weight

    Weight will be measured in kilograms pre- and post-heat challenge. We will compare change in weight between groups.

    Up to 45 minutes

  • Change in Sodium Concentration

    Sodium concentration will be measured pre- and post-heat challenge by blood draw and urine sample. Sodium concentration will be compared between groups.

    Up to 45 minutes

  • Change in Potassium Concentration

    Potassium concentration will be measured pre- and post-heat challenge by blood draw and urine sample. Potassium concentration will be compared between groups.

    Up to 45 minutes

  • Concentration of Sweat Chloride

    Sweat chloride will be measured pre- and post-heat challenge by sweat collection. Sweat chloride will be compared between groups.

    Up to 45 minutes

  • Final Score on Comfort Scale

    Participants will rate their level of comfort on a scale of 1-4 at the end of the heat challenge. Scores will be compared between groups.

    Up to 45 minutes

  • Final Score on Thermosensation Scale

    Participants will rate their level of thermosensation on a scale of 1-7 at the end of the heat challenge. Scores will be compared between groups.

    Up to 45 minutes

Study Arms (2)

CF Carriers

Participants who have previously been genotyped as CF Carriers.

Procedure: Heat Challenge

Controls

Participants who have previously been genotyped as controls and are age- and sex-matched to a CF Carrier.

Procedure: Heat Challenge

Interventions

Participants will be asked to arrive well-hydrated and to refrain from exercise, alcohol, caffeine, and smoking for 24 hours prior to the visit. Height, weight, blood pressure, and body fat percentage will be measured. Blood (15.5 ml) and urine will be collected. Participants will wear a heart rate monitor and sit in a heat chamber at 62-63 degrees Celsius for 45 minutes. Heart rate will be measured continuously. Body temperature and a self-report of their comfort (1-4 scale) and thermosensation (1-7 scale) will be measured before the challenge, every 15 minutes during the challenge, and after the challenge. During the challenge, a sample of sweat will be collected to measure electrolyte loss. Participants will consume 16 ounces of water at their own pace during the 45 minutes. If they become too uncomfortable to continue or their body temperature rises above 39 degrees Celsius, the challenge will be stopped. All baseline measures except body fat percentage will be measured again.

CF CarriersControls

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals who have previously been genotyped as CF Carriers or Controls.

You may qualify if:

  • Previously genotyped as a CF carrier or control
  • Comfortable speaking/reading English

You may not qualify if:

  • Previously genotyped as a CF patient
  • Diagnosis of Type 1 or Type 2 diabetes
  • History of heart attack, stroke, heart failure, or atherosclerosis
  • Currently pregnant
  • Currently taking beta blockers or diuretics
  • Prisoner status
  • Unable to provide own written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa Health Care

Iowa City, Iowa, 52242, United States

RECRUITING

MeSH Terms

Conditions

Heat StrokeDehydration

Condition Hierarchy (Ancestors)

Heat Stress DisordersWounds and InjuriesWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Aaron Miller, PhD

    University of Iowa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aaron Miller, PhD

CONTACT

Shelby L Francis, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

February 14, 2025

First Posted

February 26, 2025

Study Start

November 19, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 27, 2026

Record last verified: 2026-04

Locations